ClinConnect ClinConnect Logo
Search / Trial NCT06726460

Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting

Launched by ZHUJIANG HOSPITAL · Dec 6, 2024

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Electrolyte Analyzer Accuracy P1 Eaglenos

ClinConnect Summary

This clinical trial is studying a new device called the P1, which is designed to quickly measure electrolytes—important minerals in the body that help with various functions, especially in emergency situations. The goal is to see how well the P1 device works compared to an established device called the Nova Stat Profile pHOx Ultra Analyzer. Researchers will look at how consistent the results are between the two devices when measuring electrolytes in patients who are being treated in the emergency department. They will also check for abnormal levels of magnesium, which can be important for heart and muscle function.

To participate in the trial, patients aged 28 and older who are scheduled to have electrolyte testing in the emergency department or intensive care unit may be eligible. However, those with certain infectious diseases or other specific conditions might not be included. If someone joins the study, they can expect to have their electrolyte levels measured using both the P1 and Nova devices at the same time during their emergency care. This research could help determine if the P1 device can be a helpful alternative for quick electrolyte testing in emergencies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who are scheduled to undergo electrolyte measuring in the emergency department (ED) or emergency intensive care unit (ICU).
  • Exclusion Criteria:
  • Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc.
  • Missing residual sample types (serum or whole blood).
  • Patients whose residual blood samples are not tested within the specified time frame after collection.
  • Other patients deemed ineligible by the investigator.

About Zhujiang Hospital

Zhujiang Hospital, affiliated with the Southern Medical University in Guangzhou, China, is a leading clinical research institution dedicated to advancing medical science and improving patient care through rigorous clinical trials. With a strong commitment to ethical standards and patient safety, the hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals. Its state-of-the-art facilities enable the execution of innovative studies across various therapeutic areas, contributing valuable insights to the global medical community. Zhujiang Hospital aims to foster collaboration with academic institutions, pharmaceutical companies, and regulatory bodies to ensure the successful development of new therapies and enhance treatment options for patients.

Locations

Guangzhou, Guangdong, China

Patients applied

0 patients applied

Trial Officials

Hua Xie

Principal Investigator

Zhujiang Hospital, Southern Medical University Organization

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported